Publications by authors named "David Revelli"

Claim this Profile
I
Inhalable dry powders of a monoclonal antibody against SARS-CoV-2 virus made by thin-film freeze-drying.
Haiyue Xu, Sawittree Sahakijpijarn, Chaeho Moon, Christopher J Emig, Marco Mena, David Revelli

Int J Pharm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of primary immunization route on the outcome of infection with SARS-CoV-2 in a hamster model of COVID-19.
Edward G Barrett, David Revelli, Chandra Shekhar Bakshi, Alan Kadish, Salomon Amar

Front Microbiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Observed Reductions in the Infectivity of Bioaerosols Containing Bovine Coronavirus Under Repetitively Pulsed RF Exposure.
Brad W Hoff, Zane W Cohick, Burt S Tilley, John W Luginsland, David Revelli

IEEE Trans Biomed Eng· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and Pharmacodynamic Effects of Polyclonal Antibodies against SARS-CoV2 in Mice.
Aruni Jha, Melanie Doyle-Eisele, David Revelli, Trevor Carnelley, Douglas Barker

Viruses· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
Charles Jakielaszek, Mohammad Hossain, Lian Qian, Cindy Fishman, Katherine Widdowson, David Revelli

Sci Transl Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation delivery dramatically improves the efficacy of topotecan for the treatment of local and distant lung cancer.
Philip J Kuehl, Christin M Yingling, Devon Dubose, Michael Burke, David A Revelli

Drug Deliv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Treatment of Non-small Cell Lung Cancer with a Spray-Dried Bevacizumab Formulation.
Kimberly B Shepard, David T Vodak, Philip J Kuehl, David Revelli, Yue Zhou

AAPS PharmSciTech· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonlinear transmission line-driven apparatus for short-pulse microwave exposure of aerosolized pathogens.
Daniel A Enderich, Brad W Hoff, Michael Geiler, Anton Geiler, Casey Ottesen, David Revelli

Rev Sci Instrum· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apparatus for controlled microwave exposure of aerosolized pathogens.
Brad W Hoff, Jeremy W McConaha, Zane W Cohick, Matthew A Franzi, Daniel A Enderich, David Revelli

Rev Sci Instrum· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming.
Philip J Kuehl, Carmen S Tellez, Marcie J Grimes, Thomas H March, Mathewos Tessema, David A Revelli

Br J Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model.
Philip J Kuehl, Marcie J Grimes, Devon Dubose, Michael Burke, David A Revelli

Drug Deliv· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis.
David A Revelli, Julie A Boylan, Frank C Gherardini

Front Cell Infect Microbiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis